Wall Street Slips as Tech Stocks Slide on AI Spending Fears and Earnings Concerns 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
Indonesian Stocks Plunge as MSCI Downgrade Risk Sparks Investor Exodus 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Trump Threatens 50% Tariff on Canadian Aircraft Amid Escalating U.S.-Canada Trade Dispute 
Gold Prices Pull Back After Record Highs as January Rally Remains Strong 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies 
Wall Street Slides as Warsh Fed Nomination, Hot Inflation, and Precious Metals Rout Shake Markets 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook 
U.S. and El Salvador Sign Landmark Critical Minerals Agreement to Boost Investment and Trade 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Korea Ginseng Corp. said that a collaborative research team that it co-supports with Konyang University has found a potential mechanism in red ginseng polysaccharides that reduces cognitive decline in Alzheimer's disease.
The mechanism that red ginseng polysaccharides are related to synaptic and mitochondrial pathways in Alzheimer's disease was identified in this year’s research.
With an analysis of the protein-protein interaction of 111 proteins significantly changed by injecting red ginseng polysaccharide in mice, the research team found that the protein interaction decreased significantly.
Bioinformatics analysis confirmed that these proteins play an important role in nerve and synaptic development and function related to Alzheimer's disease, contributing to the preservation of mitochondrial forms.
How red ginseng polysaccharides do this was not fully clarified due to a lack of research two years ago.
"This study is meaningful because it has confirmed the possibility of red ginseng polysaccharides as candidates for effective treatments of Alzheimer's disease in animal models,” said Moon Min-ho, a professor at the College of Medicine at Konyang University.
In 2021, Konyang University’s Research Institute for Dementia Science, led by Professor Moon Min-ho, and Korea Ginseng Corporation's Research Institute team, led by Lee Yong-yook, announced in the international scientific journal Free Radical Biology and Medicine that red ginseng polysaccharide inhibits amyloid beta aggregation.
Alzheimer's occurs when amyloid beta, a proposed cause of Alzheimer's, aggregates and accumulates in the brain.
